Who owns PHIO PHARMACEUTICALS?
- Ticker: PHIO
- CUSIP Number: 71880w402
Tip: Access positions for across all investors
Analyze quarterly positions in Phio Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Phio Pharmaceuticals stock
Who bought or sold PHIO PHARMACEUTICALS this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Virtu Financial | 31k | $21k | 62% | Mar 2024 |
|
| Cetera Investment Advisers | 30k | $21k | 185% | Mar 2024 |
|
| Vanguard Group | 24k | $17k | 0% | Mar 2024 |
|
| Bridgeway Capital Management | 24k | $16k | 0% | Mar 2024 |
|
| Bank Of Montreal | 20k | $17k | 0% | Mar 2024 |
|
| Cambridge Investment Research Advisors | 14k | $10k | 0% | Mar 2024 |
|
| Tower Research Capital | 5.7k | $3.9k | 184% | Mar 2024 |
|
| UBS Group | 1.4k | $923.032600 | 100% | Mar 2024 |
|
| Wells Fargo & Company | 19.00 | $12.999800 | 0% | Mar 2024 |
|
| BlackRock | 1.00 | $1.000000 | 0% | Mar 2024 |
|
Who sold out of Phio Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Dec 2023 | 32k | $24k |
| Geode Capital Management | Sep 2023 | 15k | $23k |
| Morgan Stanley | Sep 2023 | 125.00 | $189.000000 |